Laura Bessen, M.D.
Board Member
C4 Therapeutics, Inc. (CCCC)Equibles does not estimate personal net worth.
Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CCCC alertsAbout Laura Bessen, M.D.
Laura Bessen, M.D. is recorded as Board Member at C4 Therapeutics, Inc. (CCCC) since July 29, 2022. C4 Therapeutics, Inc. reported in an 8-K filed August 2, 2022 that Laura Bessen, M.D. was appointed director, effective July 29, 2022. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.
“On July 29, 2022, the Company's Board of Directors (the "Board"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Donna Grogan, M.D. and Laura Bessen, M.D, as directors of the Company.”
Affiliation history
-
Current
2022-07-29–present
Company network
Leadership on record at C4 Therapeutics, Inc.
- Andrew J. Hirsch CEO
- Andrew Phillips CEO
- Ron Cooper Chairman, Board Member
- Kendra R. Adams CFO, Chief Accounting Officer
- Lauren White Chief Accounting Officer
- Mark Mossler Chief Accounting Officer
- William T. McKee Chief Accounting Officer
- Adam S. Crystal Board Member
- Donna Grogan, M.D. Board Member
- Owen P. Hughes, Jr. Board Member